Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke

Journal of Neurosurgery

Volumn 110, Issue 3, 2009, Pages 508-513

  Patil, Chirag G ^a,c   Long, Elisa F ^b   Lansberg, Maarten G ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Stanford University   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cost benefit analysis; Cost effectiveness; Mechanical thrombectomy; Stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MECHANICAL THROMBECTOMY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RECANALIZATION; SENSITIVITY ANALYSIS; SURVIVAL TIME; TREATMENT OUTCOME; BRAIN ISCHEMIA; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION TREE; ECONOMICS; MIDDLE AGED; QUALITY OF LIFE; STROKE; THROMBECTOMY;

AGED, 80 AND OVER; BRAIN ISCHEMIA; COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; MIDDLE AGED; QUALITY OF LIFE; STROKE; THROMBECTOMY;

EID: 63849312619     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.8.JNS08133     Document Type: Article

References (14)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333:1581-1587, 1995
2. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115:e478-e534, 2007
3. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P, American College of Chest Physicians: Antithrombotic and thrombotic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133:630-669, 2008
4. Chambers MG, Koch P, Hutton J: Development of a decision-analytic model of stroke care in the United States and Europe. Value Health 5:82-97, 2002 (Pubitemid 34274866)
5. Demaerschalk BM, Durocher DL: How diagnosis-related group 559 will change the US Medicare cost reimbursement ratio for stroke centers. Stroke 38:1309-1312, 2007
6. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, et al: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 50:883-890, 1998
7. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011, 1999
8. Gold MR, Siegel JE, Russell L, Weinstien M: Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996
9. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774, 2004
10. Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38:967-973, 2007
11. McDougall C, Clark W, Mayer T, Doertler A, Grunwald I, Berkefeld J, et al: The Penumbra Stroke Trial: safety and effectiveness of a new generation fo mechanical devices for clot removal in acute ischemic stroke, abstract presented at the International Stroke Meeting, February 20-22, 2008, New Orleans, LA
12. Saver JL: Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke 38:2279-2283, 2007
13. Smith WS: Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 27:1177-1182, 2006
14. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36:1432-1438, 2005 (Pubitemid 40967507)